<DOC>
	<DOCNO>NCT00319553</DOCNO>
	<brief_summary>This descriptive study evaluate safety immunogenicity ADACEL® BOOSTRIX® vaccine among US adolescent .</brief_summary>
	<brief_title>Post-licensure , Modified Double-blind , Multi-center Study Evaluating Safety Immunogenicity ADACEL® BOOSTRIX®</brief_title>
	<detailed_description />
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Tetany</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Aged 11 18 year age time vaccination trial Signed Institutional Review Board ( IRB ) approve informed assent / consent form . Able attend schedule visit comply trial procedure . For female , negative serum/urine pregnancy test . Any condition , opinion investigator , would pose health risk participant interfere evaluation vaccine . Serious chronic disease ( i.e . cardiac , renal , neurologic , metabolic , rheumatologic , psychiatric etc ) unstable might : interfere ability participate fully study ; interfere evaluation vaccine . Known suspected impairment immunologic function . Febrile illness within last 72 hour oral temperature ≥ 100.4°F ( ≥ 38°C ) time inclusion . History document tetanus , diphtheria pertussis disease within precede 5 year . Known suspected receipt tetanus diphtheriacontaining vaccine within precede 2 year . Known suspected receipt pertussiscontaining vaccine within precede 5 year . Administration immune globulin blood product within last three month , injected oral corticosteroid therapy expect materially alter immune function within six week study vaccine . Individuals taper dose schedule oral steroid last less 7 day may include trial long receive one course within last two week prior enrollment . Received vaccine 21day period prior enrollment schedule receive vaccination enrollment prior visit 2 . Suspected known hypersensitivity vaccine component latex .</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Tetanus</keyword>
	<keyword>diphtheria</keyword>
	<keyword>acellular pertussis</keyword>
</DOC>